Hostname: page-component-78c5997874-fbnjt Total loading time: 0 Render date: 2024-11-03T02:53:09.663Z Has data issue: false hasContentIssue false

A Controlled Trial on the Value of Prochlorperazine, Trifluoperazine and Intensive Group Treatment

Published online by Cambridge University Press:  29 January 2018

M. Hamilton
Affiliation:
Section of Psychiatry, Clinical Neuropharmacology Research Centre
A. Hordern
Affiliation:
Clinical Neuropharmacology Research Centre
F. N. Waldrop
Affiliation:
Saint Elizabeth's Hospital
J. Lofft
Affiliation:
Saint Elizabeth's Hospital

Extract

The importance of non-drug factors in the response of patients treated with psychotropic agents has been widely commented upon in recent years, though very few investigations have been undertaken specifically to identify and study these factors and to determine their role in pharmacotherapy (Hamilton and Hordern, 1963).

Type
Research Article
Copyright
Copyright © Royal College of Psychiatrists, 1963

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Hamilton, M., Smith, A. L. G., Lapidus, H. E., and Cadogan, E. P. (1960). “A controlled trial of thiopropazate dihydrochloride, chlorpromazine and occupational therapy in chronic schizophrenics”, J. Ment. Sci., 106, 4055.CrossRefGoogle Scholar
Hordern, A., and Hamilton, M. (1963). “Drugs and ‘Moral Treatment’,” Brit. J. Psychiat., 109, 500509.CrossRefGoogle Scholar
Hordern, A. and Lofft, J. G. (1960). Psychopharmacology: Two studies in a mental hospital setting. A pictorial exhibit. Washington D.C.: U.S. Department of Health Education and Welfare.Google Scholar
Rees, T. P. (1957). “Back to moral treatment and community care”, J. Ment. Sci., 103, 303313.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.